Genomic profiles offer several key benefits in the field of oncology. They enable the identification of driver mutations that are critical for cancer growth, which can be targeted with specific therapies. This approach, known as precision medicine, allows for more personalized treatment plans tailored to the unique genetic makeup of an individual's cancer. Additionally, genomic profiling can help predict how a patient might respond to certain treatments, potentially improving outcomes and reducing unnecessary side effects.
